Stockscreener 앱 받기
1.33
2.31%
0.03
시간 외 거래:
1.87
0.54
+40.60%
전일 마감가:
$1.30
열려 있는:
$1.31
하루 거래량:
1.49M
Relative Volume:
4.55
시가총액:
$41.84M
수익:
-
순이익/손실:
$-69.00M
주가수익비율:
-0.4784
EPS:
-2.78
순현금흐름:
$-55.26M
1주 성능:
-0.75%
1개월 성능:
+2.31%
6개월 성능:
-76.16%
1년 성능:
-83.50%
1일 변동 폭
$1.3005
$1.37
1주일 범위
$1.30
$1.40
52주 변동 폭
$1.05
$10.00
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
명칭
Acrivon Therapeutics Inc
전화
617-207-8979
주소
480 ARSENAL WAY, SUITE 100, WATERTOWN
ACRV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics Inc
|
1.33 | 40.89M | 0 | -69.00M | -55.26M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-05 | 재개 | Piper Sandler | Overweight |
| 2025-01-31 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-09-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2024-04-29 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-01 | 개시 | JMP Securities | Mkt Outperform |
| 2023-12-15 | 재개 | Jefferies | Buy |
| 2023-10-05 | 개시 | Maxim Group | Buy |
| 2023-06-02 | 개시 | Oppenheimer | Outperform |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-04-27 | 개시 | Ladenburg Thalmann | Buy |
| 2023-04-20 | 개시 | H.C. Wainwright | Buy |
| 2022-12-12 | 개시 | Cowen | Outperform |
| 2022-12-12 | 개시 | Jefferies | Buy |
| 2022-12-12 | 개시 | Piper Sandler | Overweight |
모두보기
Acrivon Therapeutics Inc 주식(ACRV)의 최신 뉴스
What are analysts’ price targets for Acrivon Therapeutics Inc.July 2025 Momentum & Low Risk High Win Rate Stock Picks - خودرو بانک
Long term hold vs stop loss in Acrivon Therapeutics Inc.July 2025 Highlights & AI Forecast Swing Trade Picks - Newser
Is Acrivon Therapeutics Inc. a turnaround storyJobs Report & Short-Term High Return Ideas - خودرو بانک
Will Acrivon Therapeutics Inc. announce a stock splitJuly 2025 Rallies & Capital Protection Trading Alerts - خودرو بانک
What are Acrivon Therapeutics Inc.’s growth leversWeekly Risk Summary & Real-Time Buy Zone Alerts - خودرو بانک
Can Acrivon Therapeutics Inc. maintain sales growthTrade Volume Summary & Daily Entry Point Alerts - خودرو بانک
Will Acrivon Therapeutics Inc. outperform during market ralliesWeekly Trend Summary & Long-Term Capital Growth Strategies - خودرو بانک
Acrivon Therapeutics Highlights Synergy in Updated Presentation - TipRanks
Published on: 2025-09-05 14:38:56 - Newser
Custom watchlist performance reports with Acrivon Therapeutics Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser
Momentum divergence signals in Acrivon Therapeutics Inc. chartWeekly Investment Recap & Community Supported Trade Ideas - Newser
Building trade automation scripts for Acrivon Therapeutics Inc.2025 Geopolitical Influence & Stepwise Swing Trade Plans - Newser
Multi factor analysis applied to Acrivon Therapeutics Inc.July 2025 Short Interest & Fast Entry and Exit Trade Plans - Newser
Market reaction to Acrivon Therapeutics Inc.’s recent newsWeekly Gains Report & Community Trade Idea Sharing - Newser
Acrivon Therapeutics Inc. stock trend outlook and recovery pathEarnings Recap Report & Consistent Return Strategy Ideas - Newser
Does Acrivon Therapeutics Inc. stock have upside surprise potentialJuly 2025 Momentum & Long-Term Growth Portfolio Plans - خودرو بانک
Acrivon Therapeutics Inc. stock chart pattern explainedMarket Trend Review & Weekly Momentum Stock Picks - Newser
Is this a good reentry point in Acrivon Therapeutics Inc.July 2025 Macro Moves & Weekly High Return Opportunities - Newser
Is Acrivon Therapeutics Inc. stock bottoming outTrade Analysis Report & Verified Chart Pattern Trade Signals - Newser
Will Acrivon Therapeutics Inc. continue its uptrend2025 Breakouts & Breakdowns & Real-Time Volume Triggers - Newser
Visual analytics tools that track Acrivon Therapeutics Inc. performance2025 Price Momentum & Verified Trade Idea Suggestions - Newser
How to build a dashboard for Acrivon Therapeutics Inc. stockEarnings Summary Report & Growth Oriented Trade Recommendations - Newser
Real time breakdown of Acrivon Therapeutics Inc. stock performanceQuarterly Trade Review & Safe Entry Point Identification - Newser
Forecasting Acrivon Therapeutics Inc. price range with options dataJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Detecting support and resistance levels for Acrivon Therapeutics Inc.Weekly Profit Report & High Return Trade Guides - Newser
Understanding Acrivon Therapeutics Inc.’s price movement2025 Volatility Report & Intraday High Probability Alerts - Newser
What dividend growth rate does Acrivon Therapeutics Inc. offer2025 Key Lessons & Detailed Earnings Play Strategies - خودرو بانک
Is Acrivon Therapeutics Inc. trending in predictive chart modelsJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Has Acrivon Therapeutics Inc. found a price floorSwing Trade & Safe Entry Point Alerts - Newser
Relative strength of Acrivon Therapeutics Inc. in sector analysisJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser
Should you hold or exit Acrivon Therapeutics Inc. now2025 Big Picture & Technical Buy Zone Confirmations - Newser
Has Acrivon Therapeutics Inc. formed a bullish divergenceJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Is Acrivon Therapeutics Inc. stock suitable for long term investing2025 Short Interest & Entry and Exit Point Strategies - خودرو بانک
Is Acrivon Therapeutics Inc. stock entering bullish territory2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
Full technical analysis of Acrivon Therapeutics Inc. stockJuly 2025 Decliners & High Conviction Buy Zone Picks - Newser
Tick level data insight on Acrivon Therapeutics Inc. volatilityJuly 2025 Momentum & Entry and Exit Point Strategies - Newser
Acrivon Therapeutics Inc. stock prediction for this week2025 Price Momentum & High Accuracy Swing Trade Signals - Newser
Does Acrivon Therapeutics Inc. have declining or rising EPS2025 Short Interest & Step-by-Step Swing Trade Plans - خودرو بانک
How to read the order book for Acrivon Therapeutics Inc.2025 Big Picture & Technical Confirmation Alerts - Newser
Acrivon Therapeutics Inc (ACRV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acrivon Therapeutics Inc 주식 (ACRV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
May 01 '25 |
Sale |
1.34 |
298,886 |
400,507 |
3,104,139 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 25 '25 |
Sale |
1.95 |
1,054,669 |
2,056,605 |
4,306,189 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 29 '25 |
Sale |
1.41 |
250,000 |
352,500 |
3,840,906 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 28 '25 |
Sale |
1.56 |
215,283 |
335,841 |
4,090,906 |
1.40%
자본화:
|
볼륨(24시간):